Get the Stockscreener App
3.00
6.83%
-0.22
After Hours:
3.15
0.15
+5.00%
InspireMD Inc. Stock (NSPR) Latest News
InspireMD (NYSE:NSPR) Now Covered by StockNews.com - Defense World
InspireMD, Inc. to Host Earnings Call - ACCESS Newswire
InspireMD announces inducement grants under Nasdaq listing rule - MSN
InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
When Will InspireMD Release Its 2024 Results? Key Date for Carotid Stent Maker Announced - StockTitan
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Is InspireMD's Hiring Spree a Signal for Investors? Company Awards 138K Shares to New Talent - StockTitan
Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five years - Yahoo Finance
InspireMD and NAMSA to begin study of carotid stent system for TCAR procedures - Yahoo
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal - GlobeNewswire
InspireMD And NAMSA To Partner On CGuardians II Pivotal Clinical Trial Of The CGuard Prime 80 Cm Carotid Stent System For Use In TCAR Procedures - Marketscreener.com
Major Clinical Trial Alert: InspireMD's Revolutionary TCAR Stent Targets $1B+ Market - StockTitan
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
Key Executive Compensation Alert: InspireMD Awards Strategic Stock Package to New Hire - StockTitan
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
Investors in InspireMD (NASDAQ:NSPR) from five years ago are still down 86%, even after 10% gain this past week - Simply Wall St
Compliance Issues And Stock Developments Hit Nasdaq Companies - Evrim Ağacı
InspireMD Awards Strategic Employee Stock Grants to Accelerate Growth, Adds 9 New Hires - StockTitan
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD : Breakthrough device in clinical trials aims to prevent strokes -January 20, 2025 at 07:59 am EST - Marketscreener.com
Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation - Yahoo Finance
InspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.com - MarketBeat
InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - MarketBeat
InspireMD, Inc. CFO Craig Shore to Retire, Company Initiates Search for SuccessorDecember 12, 2024 - Defense World
NSPRInspireMD, Inc. Latest Stock News & Market Updates - StockTitan
Medical device company kicks off search for next CFO - The Business Journals
InspireMD CFO Craig Shore to retire, successor search underway - Investing.com India
InspireMD CFO Retirement Amid Strategic Transition - TipRanks
InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025 - GlobeNewswire
InspireMD CFO to Retire After 15 Years Amid Crucial FDA Approval Timeline for Stroke Prevention Device - StockTitan
NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study - MSN
Lake Street Initiates Coverage of InspireMD (NSPR) with Buy Recommendation - MSN
InspireMD Announces First Patient Enrolled in CGUARDIANS II Pivotal Study - Defense World
Inspiremd Announces First Patient Enrolled in the Cguardians Ii Pivotal Study of the Cguard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures - Marketscreener.com
InspireMD Advances CGuard Prime with New Clinical Trial - TipRanks
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR) - GlobeNewswire
InspireMD Launches Pivotal CGUARDIANS II Trial for Revolutionary Carotid Stent System - StockTitan
Head to Head Contrast: Penumbra (NYSE:PEN) vs. InspireMD (NYSE:NSPR) - Defense World
InspireMD adds medtech veteran Scott Ward to its board By Investing.com - Investing.com South Africa
1.02%
2.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):